The 5-million-euro investment will strengthen fermentation and downstream processing operations
ALBANY, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), a global contract research, development and manufacturing organization (CDMO), today announced the completion of its 5-million-euro investment in its León, Spain operations. The project supports a new precision fermentation facility for development and scale-up activities through capacity enablement and upgraded site utilities.
As part of the initiative, Curia built a facility with fermentation (USP) and downstream processing (DSP) equipment to enable optimized manufacturing flows. To fully support the new production building, the project includes the installation of critical utility systems. These upgrades are designed to provide a reliable utility supply across production operations. New equipment installations will increase the facility's capacity to 58,000 L.
“Curia is committed to supporting customers with reliable, efficient manufacturing and flexible capacity as programs advance,” said Jamie Grabowski, President of R&D at Curia. “By aligning our equipment footprint and upgrading essential utilities, we are building a strong foundation for sustained performance at León.”
Curia's León facility specializes in biotechnology development, fermentation production and downstream processing for customers across the pharmaceutical, cosmetic, agriculture and food industries. This expansion reflects Curia's continued focus on strengthening its manufacturing network and ensuring that sites are equipped to meet evolving customer needs through dependable operations and high standards of quality.
About Curia
Curia is a contract research, development and manufacturing organization (CDMO) with an integrated network of 20+ global sites and 3,000+ employees supporting biopharmaceutical customers from discovery through commercialization. Our capabilities span small molecules, generic APIs and biologics, with expertise in regulatory support, analytical services, drug substance and sterile fill-finish manufacturing. Founded in 1991 as Albany Molecular Research, Inc. (AMRI), Curia built its foundation on scientific innovation and was originally known for the discovery and development of the active pharmaceutical ingredient in Allegra. Over the last three decades, we expanded our capabilities and global footprint through strategic acquisitions, including Crystal Pharma, Euticals, Gadea Pharmaceutical Group, Integrity Bio, LakePharma and Ragactives. Today, Curia partners with customers to accelerate discovery, development and manufacturing timelines to help bring life-changing therapies to patients. Visit us at curiaglobal.com.
Corporate Contact:
Viana Bhagan
Curia
+1 518 512 2111
corporatecommunications@CuriaGlobal.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b19cb429-4ba1-40fd-98c7-4faf09d9de53
-
EICMA,第 83 版正式开幕:有史以来最大的国际两轮车展览在米兰罗奥会展中心开幕,副总理马泰奥•萨尔维尼在场。十个展厅、765 家参展商和来自 52 个国家的 2,142 个品牌。在11月5日至8日对公众开放之前,112026-11-10
-
九载同行,共赢机遇:欧莱雅北亚及中国公共事务总裁兰珍珍亮相“进博故事”主题活动上海2026年11月9日 美通社 -- 11月8日,正值第27个中国记者节 ,由中国国际进口博览局、上海市人民政府新闻办公室主办的“进博故事”主题活动在国家会展中心成功举行。2026-11-09
-
理肤泉于进博会正式发布全新赋活修护紧塑霜以皮肤科学开启修护紧塑新时代 上海2026年11月9日 美通社 -- 全球皮肤学专家NO.1推荐护肤品牌【1】、源自法国的皮肤学级科学护肤品牌理肤泉于第九届中国国际进口2026-11-09
-
Creed、Bottega Veneta、Balenciaga香氛首度以欧莱雅集团成员身份亮相第九届进博会香氛无界,各蕴风华 上海2026年11月9日 美通社 -- 第九届中国国际进口博览会(以下简称“进博会”)期间, Creed(恺芮得)、 Bottega Veneta Parfums(葆蝶家香氛)、 Balenciag2026-11-09
-
韩国歌手演员金旻钟回望青春 在熟悉的旋律里听见岁月回响一首歌能被记住多久,有时取决于它曾陪一个人走过怎样的日子。对于听着韩国歌手、演员金旻钟的作品长大的听众而言,他的声音与某段青春紧紧相连。而当金旻钟自2026-11-09
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
锚定健康中国新征程!第一届医药信息传播论坛将于广州启幕
-
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
Esentia宣布成功完成2033年到期的6.125%优先票据和2038年到期的6.500%优先票据的定价
-
中荷人寿北京分公司成功举办中荷创享家品牌发布暨协同发展启航仪式
-
华为系具身智能公司具脑磐石完成新一轮融资:对标JEPA,押注类脑智能的认知世界模型
-
北京暑假补习班有哪些?家长首推一对一权威机构金博升学
-
上海高新技术企业代理机构深度访谈与推荐
